Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Pseudomonas aeruginosa is a significant pathogen in hospital-acquired infections.
• This bacterium readily develops antibiotic resistance via mutations or acquiring resistance genes.
• The rise of multi-drug-resistant (MDR) and extensively-drug-resistant (XDR) P. aeruginosa, particularly high-risk clones like ST175, poses a major clinical challenge.

Purpose of the Study:

• To highlight the clinical threat posed by MDR/XDR Pseudomonas aeruginosa.
• To underscore the challenges in treating infections caused by these resistant strains.
• To emphasize the potential of novel antibiotics in combating MDR/XDR P. aeruginosa.

Main Methods:

• Literature review on Pseudomonas aeruginosa antibiotic resistance mechanisms.
• Analysis of the prevalence and impact of high-risk clones (e.g., ST175).
• Review of current and emerging therapeutic strategies against MDR/XDR P. aeruginosa.

Main Results:

• P. aeruginosa exhibits significant antibiotic resistance through genetic mechanisms.
• Dissemination of clones like ST175 contributes to the prevalence of MDR/XDR isolates.
• Treatment selection for MDR/XDR P. aeruginosa infections is severely limited.

Conclusions:

• MDR/XDR Pseudomonas aeruginosa infections represent a critical threat in healthcare settings.
• Effective treatment options are urgently needed to manage these infections.
• New antibiotic development is crucial for addressing the challenge of drug-resistant P. aeruginosa.